Академический Документы
Профессиональный Документы
Культура Документы
Factors Influencing the Transfer of Drugs from Mother to Infant in Breast Milk
Factors that affect the concentration of drug in the mother
Drug dose, frequency, route, and patient compliance Clearance rate Plasma protein binding
Prolactin
Therapeutic Uses / Preparations:
Causes of Hyperprolactinaemia Physiological (pregnancy & post-partum: oestrogen-stimulated) Hypothyroidism (causing TRH excess) (Macroprolactinaemia) Prolactinoma Hypothalamic dopamine deficiency Defective dopamine delivery Lactotroph cells insensitivity to dopamine Dopamine antagonists present
Dopamine Analogues
Bromocriptine
Ergot peptide alkaloid Highly selective dopamine receptor agonist. Weak a-adrenergic and 5-HT agonist. Inhibits Gi-protein coupled adenylyl cyclase Inhibits prolactin release. Inhibits growth hormone release, especially in GH-secreting tumours which co-secrete prolactin.
Dosage once - three times daily. Safe in first 3-weeks of pregnancy Adverse Effects nausea (stimulation of medullary vomiting centre). Vasospasm at high dosage Pulmonary infiltrate in chronic use.
Dopamine Analogues
Cabergoline
very long half-life of prolactin suppression allows twiceweekly dosage. Less tendency than bromocriptine to cause nausea; probably better receptor selectivity. Newer; less experience in early pregnancy; no reason to believe a problem exists. Long-term adverse effects unknown
Phenindione
Radioactive iodine and other radiolabled elements